DK0458959T3 - Hidtil ukendte blodpladeafledte vækstfaktor B-kædeanaloger og fremgangsmåde til homogen fremstilling deraf - Google Patents

Hidtil ukendte blodpladeafledte vækstfaktor B-kædeanaloger og fremgangsmåde til homogen fremstilling deraf

Info

Publication number
DK0458959T3
DK0458959T3 DK91902366.3T DK91902366T DK0458959T3 DK 0458959 T3 DK0458959 T3 DK 0458959T3 DK 91902366 T DK91902366 T DK 91902366T DK 0458959 T3 DK0458959 T3 DK 0458959T3
Authority
DK
Denmark
Prior art keywords
analogs
pdgf
present
growth factor
novel
Prior art date
Application number
DK91902366.3T
Other languages
Danish (da)
English (en)
Inventor
Arlen Read Thomason
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/454,794 external-priority patent/US5149792A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0458959T3 publication Critical patent/DK0458959T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DK91902366.3T 1989-12-19 1990-12-17 Hidtil ukendte blodpladeafledte vækstfaktor B-kædeanaloger og fremgangsmåde til homogen fremstilling deraf DK0458959T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/454,794 US5149792A (en) 1989-12-19 1989-12-19 Platelet-derived growth factor B chain analogs
US07/624,451 US5272064A (en) 1989-12-19 1990-12-13 DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof

Publications (1)

Publication Number Publication Date
DK0458959T3 true DK0458959T3 (da) 1995-08-14

Family

ID=27037609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91902366.3T DK0458959T3 (da) 1989-12-19 1990-12-17 Hidtil ukendte blodpladeafledte vækstfaktor B-kædeanaloger og fremgangsmåde til homogen fremstilling deraf

Country Status (17)

Country Link
US (1) US5272064A (de)
EP (1) EP0458959B1 (de)
JP (1) JPH04504064A (de)
AT (1) ATE123949T1 (de)
AU (1) AU646014B2 (de)
CA (1) CA2032675A1 (de)
DE (1) DE69020335T2 (de)
DK (1) DK0458959T3 (de)
ES (1) ES2073735T3 (de)
FI (1) FI913892A0 (de)
GR (1) GR3017317T3 (de)
IE (1) IE904608A1 (de)
IL (1) IL96723A0 (de)
NO (1) NO913232D0 (de)
NZ (1) NZ236549A (de)
PT (1) PT96272A (de)
WO (1) WO1991008761A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2130748A1 (en) * 1992-02-26 1993-09-02 Michael E. Stern Use of platelet derived growth factor in ophthalmic wound healing
ZA932179B (en) * 1992-03-30 1994-09-26 Schering Corp Monomeric platelet-derived growth factor and prevention of stenosis or restenosis
ES2557741T3 (es) 2002-03-27 2016-01-28 Immunex Corporation Procedimientos para incrementar la producción de polipéptidos
AU2004209668A1 (en) * 2003-02-04 2004-08-19 Flanders Interuniversity Institute For Biotechnology VEGF-B and PDGF modulation of stem cells
BR112012000865A2 (pt) 2009-07-17 2019-09-24 T Tabor Aaron "composição e método para a modificação genética cosmética de células substancialmente intactas"
WO2012019160A1 (en) 2010-08-05 2012-02-09 Amgen Inc. Dipeptides to enhance yield and viability from cell cultures
LT2699293T (lt) 2011-04-20 2019-04-25 Amgen Inc. Automatinio purškimo prietaisas
US9133493B2 (en) 2011-04-21 2015-09-15 Amgen Inc. Method for culturing mammalian cells to improve recombinant protein production
SI2726600T1 (sl) 2011-07-01 2017-07-31 Amgen Inc. Sesalska celična kultura
WO2013033600A1 (en) 2011-09-02 2013-03-07 Amgen Inc. Pharmaceutical product and method of analysing light exposure of a pharmaceutical product
AR089231A1 (es) 2011-12-15 2014-08-06 Amgen Inc Metodo de floculacion
US20150353542A1 (en) 2013-01-14 2015-12-10 Amgen Inc. Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
PL3395423T3 (pl) 2013-03-14 2024-03-18 Amgen Inc. Usuwanie wypłukanych ligandów do oczyszczania na zasadzie powinowactwa
TWI771890B (zh) 2013-03-14 2022-07-21 美商安美基公司 用於增加重組蛋白質之甘露糖含量之方法
US10092703B2 (en) 2013-03-15 2018-10-09 Amgen Inc. Drug cassette, autoinjector, and autoinjector system
TWI592183B (zh) 2013-03-15 2017-07-21 安美基公司 本體輪廓可調適之自動注射器裝置
US10492990B2 (en) 2013-03-15 2019-12-03 Amgen Inc. Drug cassette, autoinjector, and autoinjector system
US9481901B2 (en) 2013-05-30 2016-11-01 Amgen Inc. Methods for increasing mannose content of recombinant proteins
SI3063287T1 (sl) 2013-10-31 2025-06-30 Amgen, Inc. Uporaba monenzina za regulacijo glikozilacije rekombinantnih proteinov
MX376230B (es) 2014-01-13 2025-03-07 Amgen Inc Regulación del metábolismo de ornitina para manipular el contenido de glicoformas ricas en manosa de proteínas recombinantes.
CN106170554B (zh) 2014-01-29 2021-08-17 美国安进公司 过表达n-糖基化途径调节基因以调节重组蛋白的糖基化
US10106829B2 (en) 2014-01-29 2018-10-23 Amgen Inc. Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
KR102391259B1 (ko) 2014-06-04 2022-04-26 암젠 인크 포유류 세포 배양물을 회수하는 방법
ES2962593T3 (es) 2014-11-19 2024-03-20 Amgen Inc Cuantificación de resto glucano en glucoproteínas recombinantes
CA2969225C (en) 2014-12-01 2023-08-22 Amgen Inc. Process for manipulating the level of glycan content of a glycoprotein
JP7747438B2 (ja) 2017-11-16 2025-10-01 アムジエン・インコーポレーテツド 失速及び終点検出を有するオートインジェクタ
IL307155B2 (en) 2018-05-01 2025-11-01 Amgen Inc Antibodies with modulated glycan profiles
TWI777364B (zh) 2020-01-15 2022-09-11 大陸商上海藥明生物技術有限公司 連續收穫由培養的細胞生產的生物物質的設備和方法
WO2023079058A1 (en) 2021-11-05 2023-05-11 Yokogawa Insilico Biotechnology Gmbh Cell culture with reduced production of lactate
KR20240128067A (ko) 2021-12-29 2024-08-23 브리스톨-마이어스 스큅 컴퍼니 랜딩 패드 세포주의 생성

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor
US4769328A (en) * 1984-10-12 1988-09-06 Zymogenetics Inc. Expression of biologically active PDGF analogs in yeast
US4801542A (en) * 1984-10-12 1989-01-31 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4766073A (en) * 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
EP0487116B1 (de) * 1984-10-12 1999-12-29 ZymoGenetics, Inc. Von Blutplättchen abstammende biologisch aktive Analoga eines Wachstumsfaktors in eukaryotischen Zellen
ATE131532T1 (de) * 1986-08-13 1995-12-15 Zymogenetics Inc Expression von biologisch-aktiven pdgf-analogen in eukaryotischen zellen
DE3834079A1 (de) * 1988-10-06 1990-04-12 Biotechnolog Forschung Gmbh Wachstumstimulierendes pdgf-bb und dessen verwendung sowie ein verfahren zu seiner herstellung und der des monomeren
IL96682A0 (en) * 1989-12-15 1991-09-16 Amgen Inc Production of biologically active platelet-derived growth factor from high expression host cell systems

Also Published As

Publication number Publication date
WO1991008761A1 (en) 1991-06-27
NO913232L (no) 1991-08-19
ES2073735T3 (es) 1995-08-16
AU7153491A (en) 1991-07-18
FI913892A7 (fi) 1991-08-16
GR3017317T3 (en) 1995-12-31
CA2032675A1 (en) 1991-06-20
IE904608A1 (en) 1991-06-19
NO913232D0 (no) 1991-08-19
EP0458959A1 (de) 1991-12-04
NZ236549A (en) 1993-03-26
JPH04504064A (ja) 1992-07-23
PT96272A (pt) 1991-09-30
US5272064A (en) 1993-12-21
DE69020335D1 (de) 1995-07-27
EP0458959A4 (en) 1993-06-16
ATE123949T1 (de) 1995-07-15
FI913892A0 (fi) 1991-08-16
IL96723A0 (en) 1991-09-16
AU646014B2 (en) 1994-02-03
DE69020335T2 (de) 1995-11-02
EP0458959B1 (de) 1995-06-21

Similar Documents

Publication Publication Date Title
NO913232D0 (no) Nye blodplatederiverte vekstfaktor-b-kjedeanaloger og metode for homogen produksjon av disse.
KR880007734A (ko) 폴리펩타이드 유도체
SE8105657L (sv) Mikrobiell framstellning av humanfibroblastinterferon
NO974812D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
DK164940C (da) Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet
DE69033453D1 (de) Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose
ATE91722T1 (de) Pferde-gamma-interferon.
AU7681687A (en) Expression of platelet-derived growth factor and analogues
DE3852706D1 (de) Verfahren zur Herstellung eines physiologisch aktiven Peptids mit einem Cysteinrest.
PT100651A (pt) Muteinas da interleucina 6 (il-6) isentas de cisteina
YU179489A (en) Process for preparing new derivatives of human/cattle basis fibroblast growth factor
PAN et al. Structural characterization of human interferon γ Heterogeneity of the carboxyl terminus
JPS6420095A (en) Polypeptide having anti-blood coagulating action
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
EP0330700A4 (de) Menschlicher Prourokinase ähnliches Polypeptid.
DE3782549D1 (de) Neue polypeptide, ihre herstellung und ihre verwendung.
EP0072541A3 (de) Menschliche Leukozyten-Interferone, Verfahren zu deren Mikrobiologischer Herstellung, Zwischenprodukte und diese enthaltende Zusammensetzungen
DK27097A (da) Minactivin og fremgangsmåde til fremstilling deraf
DK0555785T3 (da) Glat-muskel-mitogent stof og DNA, der koder herfor
SE8502430D0 (sv) A cdna molecule coding for the expression of an interferon alfa type polypeptide, a bacterial or cellular host transformed with such molecule and a polypeptide showing interferon activity prepared by such host
EP0613946A3 (en) Hst-2 mutein, dna coding for the same and preparation thereof.
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
Butnev et al. Multiple forms of hypophyseal prolactin. A new glycosylated form of prolactin with increased biological activity